Journal article · 2026 · Open access

Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis

Raymond G. Flax, Andrea Lacigová, Stefanie Howell, Haoxi Li, Frances M. Bashore, Lukáš Čajánek, Alison D. Axtman

Journal of Medicinal Chemistry, 69(21), 25415–25433 · Published 15 October 2026 · DOI 10.1021/acs.jmedchem.6c01323

Open PDFView at the publisherCite this paper

In brief

“Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis” is a 2026 journal article by Raymond G. Flax and 6 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 2 citations as of 16 November 2026, which puts it in the top 4% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Journal of Medicinal Chemistry.

Citations
2
Most cited in
2026 (2)
Field-weighted impact
5.30
References
42
Authors
7

Abstract

We have characterized a potent and cell active tau tubulin kinase 1 and 2 (TTBK1 and TTBK2) inhibitor, 13. Analysis of the in-cell, kinome-wide selectivity of compound 13 revealed it to only bind five of 300 kinases with >50% occupancy at 1 μM: CDK11B, CDK11A, CK1δ, CK1ε, and EPHA2. Extensive dose-response follow-up studies in cells refined the off-target kinases of compound 13 to include CDK11B, CDK11A, CK1δ, and PIKfyve based on their NanoBRET IC50 values being <1 μM. As part of our medicinal chemistry campaign, we also identified a structurally similar negative control, compound 5, which lacks in-cell affinity for TTBK1 and TTBK2. TTBK2 is an effector of ciliogenesis, acting in concert with CEP164, CP110, and CEP83 to initiate the biogenesis of primary cilia. We demonstrate that compound 13 ablates TTBK2 autophosphorylation and significantly disrupts ciliogenesis in hTERT-RPE-1 cells, making it a powerful tool compound for ciliary studies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Flax, R. G., Lacigová, A., Howell, S., Li, H., Bashore, F. M., Čajánek, L., & Axtman, A. D. (2026). Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis. Journal of Medicinal Chemistry, 69(21), 25415–25433. https://doi.org/10.1021/acs.jmedchem.6c01323

MLA 9

Flax, Raymond G., et al. “Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis.” Journal of Medicinal Chemistry, vol. 69, no. 21, 2026, pp. 25415–25433. https://doi.org/10.1021/acs.jmedchem.6c01323.

Chicago

Flax, Raymond G., Andrea Lacigová, Stefanie Howell, Haoxi Li, Frances M. Bashore, Lukáš Čajánek, and Alison D. Axtman. 2026. “Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis.” Journal of Medicinal Chemistry 69 (21): 25415–25433. https://doi.org/10.1021/acs.jmedchem.6c01323.

Harvard

Flax, R. G. et al. (2026) ‘Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis’, Journal of Medicinal Chemistry, 69(21), pp. 25415–25433. doi:10.1021/acs.jmedchem.6c01323.

IEEE

R. G. Flax et al., “Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis,” Journal of Medicinal Chemistry, vol. 69, no. 21, pp. 25415–25433, 2026, doi: 10.1021/acs.jmedchem.6c01323.

BibTeX

@article{flax2026potent,
  title     = {{Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis}},
  author    = {Flax, Raymond G. and Lacigová, Andrea and Howell, Stefanie and Li, Haoxi and Bashore, Frances M. and Čajánek, Lukáš and Axtman, Alison D.},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  volume    = {69},
  number    = {21},
  pages     = {25415--25433},
  doi       = {10.1021/acs.jmedchem.6c01323},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c01323}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases

  • 5-azaindole
  • ciliogenesis
  • kinase selectivity
  • CDK11
  • CK1δ
  • PIKfyve
  • NanoBRET

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Flax, R. G., Lacigová, A., Howell, S., Li, H., Bashore, F. M., Čajánek, L., & Axtman, A. D. (2026). Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis. Journal of Medicinal Chemistry, 69(21), 25415–25433. https://doi.org/10.1021/acs.jmedchem.6c01323

How many times has this paper been cited?

2 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Medicinal Chemistry: sign in and open the PDF from this page.

Who wrote this paper?

Raymond G. Flax, Andrea Lacigová, Stefanie Howell, Haoxi Li, Frances M. Bashore, Lukáš Čajánek, Alison D. Axtman.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c01323, permanently at https://doi.org/10.1021/acs.jmedchem.6c01323. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.